Jason Frischer, MD, director of the Colorectal Center at Cincinnati Children’s, Cincinnati, OH, discusses medical therapy with biologic agents and the impact on the surgical management of inflammatory bowel disease. According to Dr Frischer, the use of biologics has led to a dramatic improvement in endoscopic recurrence, but has had mixed results on clinical endpoints. Biologics can be safely restarted 4 weeks after surgery.